BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6133895)

  • 1. Multiple splenic lymphoid cell subpopulations regulate H-2 antigen expression on teratocarcinoma cells in vivo.
    Ostrand-Rosenberg S; Cohn AL; Sandoz JW
    J Immunol; 1983 Jun; 130(6):2969-73. PubMed ID: 6133895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-2 negative teratocarcinoma cells become H-2 positive when passaged in genetically resistant host mice.
    Ostrand-Rosenberg S; Cohan VL
    J Immunol; 1981 Jun; 126(6):2190-3. PubMed ID: 7229370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H-2 antigen expression on teratocarcinoma cells passaged in genetically resistant mice is regulated by lymphoid cells.
    Ostrand-Rosenberg S; Cohn A
    Proc Natl Acad Sci U S A; 1981 Nov; 78(11):7106-10. PubMed ID: 7031669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
    Rembecki RM; Bennett M; Kumar V; Potter TA
    J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically determined resistance to foreign bone marrow transplantation in mice: characterization of the effector cells.
    Miller SC
    J Immunol; 1983 Jul; 131(1):92-7. PubMed ID: 6345669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; OnoƩ K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class I H-2Db determinants are not involved in hybrid resistance to parental H-2b/Hh-1b bone marrow allograft.
    Milisauskas VK; Kaminsky SG; Nakamura I
    Eur J Immunol; 1987 Jul; 17(7):1043-9. PubMed ID: 2440692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P; Vourka-Karussis U; Weiss L; Slavin S
    J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells.
    Callahan GN
    J Immunol; 1984 May; 132(5):2649-57. PubMed ID: 6201554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host origin of follicular dendritic cells induced in the spleen of SCID mice after transfer of allogeneic lymphocytes.
    Yoshida K; Kaji M; Takahashi T; van den Berg TK; Dijkstra CD
    Immunology; 1995 Jan; 84(1):117-26. PubMed ID: 7890295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression on mouse lymphoid cells of Th-B, an antigen common to mouse B cells and thymus cells.
    Yutoku M; Grossberg AL; Pressman D
    J Immunol; 1975 Jul; 115(1):69-74. PubMed ID: 1097506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistology of lymphoid and non-lymphoid cells in the thymus in relation to T lymphocyte differentiation.
    Van Ewijk W
    Am J Anat; 1984 Jul; 170(3):311-30. PubMed ID: 6332520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor growth mediated by lymphocytes sensitized in vitro to a syngeneic murine teratocarcinoma 402AX.
    Bartlett PF; Fenderson BA; Edidin M
    J Immunol; 1978 Apr; 120(4):1211-7. PubMed ID: 641346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
    Boswell HS; Wade PM; Quesenberry PJ
    J Immunol; 1984 Dec; 133(6):2940-9. PubMed ID: 6149245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cells responsible for murine natural cytotoxic (NC) activity: a multi-lineage system.
    Bykowsky MJ; Stutman O
    J Immunol; 1986 Aug; 137(4):1120-6. PubMed ID: 3734456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple B29 containing complexes on murine B lymphocytes. Common and stage-restricted Ig-associated polypeptide chains.
    Ishihara K; Wood WJ; Wall R; Sakaguchi N; Michnoff C; Tucker PW; Kincade PW
    J Immunol; 1993 Mar; 150(6):2253-62. PubMed ID: 8450210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface antigens expressed by subsets of pre-B cells and B cells.
    McKearn JP; Baum C; Davie JM
    J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloantigen recognition is critical for CD8 T cell-mediated graft anti-tumor activity against murine BCL1 lymphoma after myeloablative bone marrow transplantation.
    Pillai A; Teo P; George T; Mukhopadhyay A; Dejbakhsh-Jones S; Strober S
    Bone Marrow Transplant; 2007 Sep; 40(5):487-97. PubMed ID: 17603512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.